By enriching cDC1s and CD8+/−Ly49+ Tregs, pro-healing ECM biomaterials mitigate naïve T cell retention in tissue and prevents B cell driven autoimmunity (Figure 7K). This evidence concerns the gene CD8A and Autoimmunity.